[topsearch__bar__shortcode]

May 10, 2022

ATER

Aterian Inc. (ATER) Continues Trading in the Red Following its Q1 2022 Earnings Report

As expected, Aterian Inc. (ATER) missed its Q1 2022 earnings as well as revenues when it posted the results on May 9, 2022. Investors were worried about the earnings as its history of earnings miss and declining contribution margin amid the supply chain disruptions and inflation, had been indicating another earnings miss. Thus, with worries

Aterian Inc. (ATER) Continues Trading in the Red Following its Q1 2022 Earnings Report Read More »

PLUG

Plug Power Inc. (PLUG) Disappoints on Both Earnings & Revenue in Q1 2022 Results

On May 9, 2022, Plug Power Inc. (PLUG) reported its financial results for the first quarter of 2022. Disappointing on both earnings and revenue miss, the stock plunged further deep in the after hours. Investors were already worried about the results falling short of their expectations as the stock fell by over 14% before the

Plug Power Inc. (PLUG) Disappoints on Both Earnings & Revenue in Q1 2022 Results Read More »

GDRX

GoodRx Holdings Inc. (GDRX) Sinks Post Earnings on Outlook Cut Down Due to Grocery Chain Issue

On May 9, GoodRx Holdings Inc. (GDRX) posted a beat quarterly report for Q1 2022 with revenue and earnings both above expectations. But concerns over a grocery chain issue have the company slashing down its 2022 guidance. The company said it is unlikely to achieve the previously provided outlook for the year. Thus, despite the

GoodRx Holdings Inc. (GDRX) Sinks Post Earnings on Outlook Cut Down Due to Grocery Chain Issue Read More »

XELA Stock

Exela Technologies Inc. (XELA) Under Corrections Following Financing Commitment from PNC Bank

On May 9, 2022, Exela Technologies Inc. (XELA) said that it has executed a financing commitment from PNC Bank. Consequently, the stock shot up by 28.46% in the regular trading session to trade at $0.3701 a share. Ultimately, the upsurge culminated in corrections in the following session. Thus, XELA succumbed to corrections in the after-hours

Exela Technologies Inc. (XELA) Under Corrections Following Financing Commitment from PNC Bank Read More »

Trinity

XOMA Combines Low Risk and High Biotech Gains

Summary XOMA Corporation is a royalty aggregator in the biotech sector, acquiring the economic rights to early phase treatment candidates. The wider biotech market has been seeing slumping performance throughout the last year, whereas XOMA has been delivering stellar gains, owing to the sustainability of its business model. In FY21, XOMA delivered staggering growth in

XOMA Combines Low Risk and High Biotech Gains Read More »